Cutler Group’s Ascendis Pharma A/S ASND Stock Holding History

Cutler Group’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$66K	Buy	+440	New	+$62.8K	0.02%	569
2023 Q4	–	Sell	-200	Closed	-$18K	–	3584
2023 Q3	$18K	Sell	200 -460	-70%	-$43K	﹤0.01%	2096
2023 Q2	$58K	Buy	660 +510	+340%	+$44.4K	0.01%	1207
2023 Q1	$16K	Sell	150 -50	-25%	-$5.72K	﹤0.01%	2027
2022 Q4	$24K	Buy	+200	New	+$23.2K	﹤0.01%	2082
2022 Q3	–	Sell	-1,772	Closed	-$168K	–	4882
2022 Q2	$164K	Sell	1,772 -7,883	-82%	-$743K	0.01%	1111
2022 Q1	$1.13M	Buy	+9,655	New	+$1.12M	0.06%	348
2021 Q4	–	Sell	-150	Closed	-$23K	–	5344
2021 Q3	$23K	Buy	+150	New	+$20.5K	﹤0.01%	3209
2020 Q4	–	Sell	-420	Closed	-$69.5K	–	4770
2020 Q3	$64K	Buy	+420	New	+$60.4K	﹤0.01%	1624
2020 Q2	–	Sell	-2,000	Closed	-$275K	–	4345
2020 Q1	$225K	Buy	+2,000	New	+$260K	0.01%	882
2019 Q1	–	Sell	-1,200	Closed	-$105K	–	3996
2018 Q4	$75K	Buy	+1,200	New	+$75.4K	0.01%	1232
2018 Q3	–	Sell	-800	Closed	-$55.1K	–	4063
2018 Q2	$53K	Buy	+800	New	+$52.6K	﹤0.01%	1568

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Cutler Group's ASND Position: Q1 2024 in Review

Cutler Group opened a new position in Ascendis Pharma A/S (ASND) in Q1 2024: 440 shares worth $66K. The stake represents 0.02% of the portfolio and ranks #569 among its holdings. This is a return to the name: Cutler Group previously reported a position in ASND as recently as Q3 2023.

Cutler Group first reported a position in ASND in Q2 2018 and has held it in 12 quarters since. The position peaked at $1.13M in Q1 2022. 189 funds tracked by Wall St. Rank hold ASND as of Q1 2024.

Cutler Group held 440 shares of Ascendis Pharma A/S worth $66K as of Q1 2024.
Ascendis Pharma A/S was a new Cutler Group position in Q1 2024.
Ascendis Pharma A/S made up 0.02% of Cutler Group's portfolio in Q1 2024, its #569 holding.
Cutler Group first reported a position in Ascendis Pharma A/S in Q2 2018 and has held it in 12 quarters since.
Cutler Group's Ascendis Pharma A/S position peaked at $1.13M in Q1 2022.
189 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.